Higher PRAL and NEAP were associated with worse kidney function after 1 year of follow-up as measured by eGFR and UACR markers in an older Spanish population with overweight/obesity and metabolic syndrome. Here, PRAL is linked to obesity due to melanocortin 4 receptor deficiency.